We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
(+13%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
18.39%
Top 10 Holdings %
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$34.6M |
| 2 |
Workday
WDAY
|
+$33.5M |
| 3 |
FRC
First Republic Bank
FRC
|
+$31.8M |
| 4 |
Zoetis
ZTS
|
+$31.3M |
| 5 |
Synchrony
SYF
|
+$31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$35.7M |
| 2 |
Honeywell
HON
|
+$31.7M |
| 3 |
International Paper
IP
|
+$30.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$23.8M |
| 5 |
Emerson Electric
EMR
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.12% |
| 2 | Financials | 17.75% |
| 3 | Healthcare | 12.17% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Chemours
CC
$2.23B
| $1.07M | 0.01% |
34,070
-69,974
| -67% | -$2.19M |
|
1977
Teledyne Technologies
TDY
$31.6B
| $1.07M | 0.01% |
2,266
-22,597
| -91% | -$9.72M |
|
|
LITT
1978
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
| $1.07M | 0.01% |
110,030
+20,439
| +23% | +$198K |
|
1979
Enpro
NPO
$7.12B
| $1.07M | 0.01% |
10,916
+4,483
| +70% | +$477K |
|
1980
Valaris
VAL
$6.03B
| $1.07M | 0.01% |
20,504
-26,893
| -57% | -$1.16M |
|
1981
Ingredion
INGR
$6.6B
| $1.06M | 0.01% |
12,179
-47,228
| -79% | -$4.27M |
|
|
CSII
1982
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.06M | 0.01% |
46,862
-129,996
| -74% | -$2.52M |
|
1983
CALL
Chevron
CVX
$386B
| $1.06M | 0.01% |
+6,500
| New | +$932K |
|
1984
Kite Realty
KRG
$5.24B
| $1.06M | 0.01% |
46,486
-71,773
| -61% | -$1.56M |
|
1985
Ross Stores
ROST
$80.8B
| $1.06M | 0.01% |
11,690
-16,244
| -58% | -$1.55M |
|
1986
MacroGenics
MGNX
$249M
| $1.06M | 0.01% |
119,897
+79,046
| +193% | +$873K |
|
1987
Equinox Gold
EQX
$13.6B
| $1.05M | 0.01% |
127,624
+107,023
| +520% | +$753K |
|
1988
Marten Transport
MRTN
$1.18B
| $1.05M | 0.01% |
59,170
-14,311
| -19% | -$251K |
|
|
TVTY
1989
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.05M | 0.01% |
32,612
-3,245
| -9% | -$87.7K |
|
1990
AstraZeneca
AZN
$246B
| $1.05M | 0.01% |
7,902
+333
| +4% | +$39.9K |
|
|
ZEN
1991
DELISTED
ZENDESK INC
ZEN
| $1.05M | 0.01% |
8,714
-17,542
| -67% | -$1.91M |
|
1992
Sturm, Ruger & Co
RGR
$598M
| $1.04M | 0.01% |
14,984
-7,704
| -34% | -$530K |
|
1993
Cohen & Steers
CNS
$4.34B
| $1.04M | 0.01% |
12,101
+6,232
| +106% | +$516K |
|
1994
National Health Investors
NHI
$3.39B
| $1.04M | 0.01% |
17,604
-15,962
| -48% | -$909K |
|
1995
Tenaris
TS
$27B
| $1.04M | 0.01% |
34,555
-37,462
| -52% | -$975K |
|
|
PLAN
1996
DELISTED
Anaplan, Inc.
PLAN
| $1.03M | 0.01% |
15,805
-122,511
| -89% | -$5.97M |
|
1997
Morningstar
MORN
$7.33B
| $1.02M | 0.01% |
3,752
+3,496
| +1,366% | +$988K |
|
1998
Teva Pharmaceuticals
TEVA
$42.5B
| $1.02M | 0.01% |
109,188
-226,045
| -67% | -$1.89M |
|
|
GAP
1999
The Gap Inc
GAP
$7.55B
| $1.02M | 0.01% |
72,757
+14,846
| +26% | +$237K |
|
|
Y
2000
DELISTED
Alleghany Corp
Y
| $1.02M | 0.01% |
1,209
-9,837
| -89% | -$6.81M |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2022 Portfolio in Review
As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.
- Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
- Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
- Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
- Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
- Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
- Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
- Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.